[HTML][HTML] Therapeutic implications of current Janus kinase inhibitors as anti-COVID agents: A review
NK Jain, M Tailang, HK Jain… - Frontiers in …, 2023 - frontiersin.org
Severe cases of COVID-19 are characterized by hyperinflammation induced by cytokine
storm, ARDS leading to multiorgan failure and death. JAK-STAT signaling has been …
storm, ARDS leading to multiorgan failure and death. JAK-STAT signaling has been …
Therapeutic implications of current Janus kinase inhibitors as anti-COVID agents: A review
NK Jain, M Tailang, HK Jain… - Frontiers in …, 2023 - pubmed.ncbi.nlm.nih.gov
Severe cases of COVID-19 are characterized by hyperinflammation induced by cytokine
storm, ARDS leading to multiorgan failure and death. JAK-STAT signaling has been …
storm, ARDS leading to multiorgan failure and death. JAK-STAT signaling has been …
[PDF][PDF] Therapeutic implications of current Janus kinase inhibitors as anti-COVID agents: A review
NK Jain, M Tailang, HK Jain, B Chandrasekaran… - 2023 - scienceopen.com
Over the last 30 years, research has established Janus kinases (JAKs) as a lucrative target
for drug development against various autoimmune, allergic, and inflammatory diseases …
for drug development against various autoimmune, allergic, and inflammatory diseases …
[HTML][HTML] Therapeutic implications of current Janus kinase inhibitors as anti-COVID agents: A review
NK Jain, M Tailang, HK Jain… - Frontiers in …, 2023 - ncbi.nlm.nih.gov
Severe cases of COVID-19 are characterized by hyperinflammation induced by cytokine
storm, ARDS leading to multiorgan failure and death. JAK-STAT signaling has been …
storm, ARDS leading to multiorgan failure and death. JAK-STAT signaling has been …
Therapeutic implications of current Janus kinase inhibitors as anti-COVID agents: a review.
NK Jain, M Tailang, HK Jain, B Chandrasekaran… - 2023 - cabidigitallibrary.org
Severe cases of COVID-19 are characterized by hyperinflammation induced by cytokine
storm, ARDS leading to multiorgan failure and death. JAK-STAT signaling has been …
storm, ARDS leading to multiorgan failure and death. JAK-STAT signaling has been …
[PDF][PDF] Therapeutic implications of current Janus kinase inhibitors as anti-COVID agents: A review
NK Jain, M Tailang, HK Jain, B Chandrasekaran… - 2023 - researchgate.net
Over the last 30 years, research has established Janus kinases (JAKs) as a lucrative target
for drug development against various autoimmune, allergic, and inflammatory diseases …
for drug development against various autoimmune, allergic, and inflammatory diseases …
[PDF][PDF] Therapeutic implications of current Janus kinase inhibitors as anti-COVID agents: A review
NK Jain, M Tailang, HK Jain, B Chandrasekaran… - 2023 - academia.edu
Over the last 30 years, research has established Janus kinases (JAKs) as a lucrative target
for drug development against various autoimmune, allergic, and inflammatory diseases …
for drug development against various autoimmune, allergic, and inflammatory diseases …
Therapeutic implications of current Janus kinase inhibitors as anti-COVID agents: A review.
NK Jain, M Tailang, HK Jain… - Frontiers in …, 2023 - europepmc.org
Severe cases of COVID-19 are characterized by hyperinflammation induced by cytokine
storm, ARDS leading to multiorgan failure and death. JAK-STAT signaling has been …
storm, ARDS leading to multiorgan failure and death. JAK-STAT signaling has been …
[引用][C] Therapeutic implications of current Janus kinase inhibitors as anti-COVID agents: A review
NK Jain, M Tailang, HK Jain… - Frontiers in …, 2023 - jglobal.jst.go.jp
AgrawalM., BrennerE. J., ZhangX., ModestoI., WoolcottJ., UngaroR. C., et al (2021).
Characteristics and outcomes of IBD patients with COVID-19 on tofacitinib therapy in the …
Characteristics and outcomes of IBD patients with COVID-19 on tofacitinib therapy in the …
[PDF][PDF] Therapeutic implications of current Janus kinase inhibitors as anti-COVID agents: A review
NK Jain, M Tailang, HK Jain, B Chandrasekaran… - 2023 - academia.edu
Over the last 30 years, research has established Janus kinases (JAKs) as a lucrative target
for drug development against various autoimmune, allergic, and inflammatory diseases …
for drug development against various autoimmune, allergic, and inflammatory diseases …